BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information letter on emergency hormonal contraceptives (e.g. Postinor®): New recommendations for women taking CYP3A4 inducers

Active substance: levonorgestrel

The company Gedeon Richter Pharma GmbH is circulating new recommendations for women taking liver enzyme inducers. Active substances that trigger such an induction include e.g. preparations containing St. John's wort, rifampicin, certain HIV medicines or antiepileptic agents.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 93KB, File does not meet accessibility standards